title: [New methods of treatment of age-related macular degeneration. Photodynamic therapy. Part I].
abstract: Neovascular form of Age-related Macular Degeneration is the leading cause of blindness in developed countries. There is un urgent need for the effective treatment. In the recent years a number of treatment methods has been investigated. Photodynamic Therapy (PDT) with verteporfin appears to be an exciting approach to treatment which may provide a major breakthrough. The benefits of PDT with verteporfin were proved in randomized clinical trials--Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) study.
authors.affiliation: I Kliniki Okulistyki Slaskiej Akademii Medycznej w Katowicach.
authors.forename: Ariadna
authors.initials: A
authors.lastname: Gierek-Łapińska
authors.forename: Halina
authors.initials: H
authors.lastname: Wykrota
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Trzciakowski
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000473:pathology; D005584:Fovea Centralis; D006801:Humans; D008268:Macular Degeneration / Q000150:complications* / Q000473:pathology; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D000077362:Verteporfin; D014786:Vision Disorders / Q000188:drug therapy / Q000209:etiology; D014792:Visual Acuity
chemical_list: D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin